Current management of breakthrough cancer pain according to physicians from pain units in Spain


Por: Estevez F, Alarcon M, Mayoral V, de Madariaga M, Margarit C, Duran J, Martin-Arroyo J, Carregal A, SED

Publicada: 1 sep 2019
Resumen:
PurposeCurrent evidence suggests the need to improve the management of breakthrough cancer pain (BTcP). For this reason, we aimed to assess the opinion of a panel of experts composed exclusively of physicians from pain units, who play a major role in BTcP diagnosis and treatment, regarding the key aspects of BTcP management.MethodsAn ad hoc questionnaire was developed to collect real-world data on the management of BTcP. The questionnaire had 5 parts: (a) organizational aspects of pain units (n=12), (b) definition and diagnosis (n=3), (c) screening (n=3), (d) treatment (n=8), and (e) follow-up (n=7).ResultsA total of 89 pain-unit physicians from 13 different Spanish regions were polled. Most of them agreed on the traditional definition of BTcP (78.9%) and the key features of BTcP (92.1%). However, only 30.3% of participants used the Davies' algorithm for BTcP diagnosis. Respondents preferred to prescribe rapid-onset opioids [mean 77.0% (SD 26.7%)], and most recommended transmucosal fentanyl formulations as the first option for BTcP. There was also considerable agreement (77.5%) on the need for early follow-up (48-72h) after treatment initiation. Finally, 65.2% of participants believed that more than 10% of their patients underused rapid-onset opioids.ConclusionsThere was broad agreement among pain experts on many important areas of BTcP management, except for the diagnostic method. Pain-unit physicians suggest that rapid-onset opioids may be underused by BTcP patients in Spain, an important issue that need to be evaluated in future studies.

Filiaciones:
Estevez F:
 Consorcio Hosp Prov Castellon, Pain Unit, Castellon de La Plana, Spain

Alarcon M:
 Univ Valencia, Hosp Gen, Pain Unit, Valencia, Spain

Mayoral V:
 Hosp Univ Bellvitge, Pain Unit, Barcelona, Spain

de Madariaga M:
 Hosp Univ Infanta Sofia, Pain Unit, Madrid, Spain

Margarit C:
 Univ Alicante, Hosp Gen, Pain Unit, Alicante, Spain

Duran J:
 Hosp Univ Nuestra Senora Candelaria, Hosp Santa Cruz Tenerife, Pain Unit, Tenerife, Spain

Martin-Arroyo J:
 Hosp Puerta Mar, Pain Unit, Cadiz, Spain

Carregal A:
 Complexo Hosp Univ Vigo CHUVI, Pain Unit, Pontevedra, Spain
ISSN: 1699048X





CLINICAL & TRANSLATIONAL ONCOLOGY
Editorial
SPRINGER-VERLAG ITALIA SRL, VIA DECEMBRIO, 28, MILAN, 20137, ITALY, Italia
Tipo de documento: Article
Volumen: 21 Número: 9
Páginas: 1168-1176
WOS Id: 000477679100007
ID de PubMed: 30783918

MÉTRICAS